Healthcare Law Today

NOVEMBER 9, 2022

Starting January 1, 2023, Medicare will cover telehealth-based treatment services delivered by federally-accredited opioid treatment programs (OTPs), commonly referred to as “methadone clinics.” Background and History of Medicare Telehealth Coverage of SUD Treatment. New Changes to Medicare OTP Telehealth Services.

Medicare 52

Medicare Medicare COVID-19 Telemedicine 52

Healthcare Compliance Blog

MAY 18, 2022

The program is funded by the Centers for Medicare & Medicaid Services (CMS), and will establish a Center of Excellence for Building Capacity in Nursing Facilities to Care for Residents with Behavioral Health Conditions (Center for Excellence).

Nursing Homes 59

Nursing Homes Nurses Health Services Administration Medicaid 59

Health Law Advisor

MARCH 7, 2023

The proposed rules also clarify that a telemedicine encounter that results in a controlled substance prescription requires the health care professional treating the patient to use an interactive telecommunications system, and directly refers to the Medicare definition of that term at 42 C.F.R. 15, 2022), [link] 21 U.S.C. §

Telemedicine 52

Telemedicine COVID-19 FDA Compliance 52

HIPAA Journal

MAY 12, 2023

The proposed changes – if finalized – will not only impact HIPAA compliance , but other federal Rules that govern uses and disclosures of PHI (i.e., Update to CMS Interoperability and Patient Access Final Rule In 2020, the Centers for Medicare and Medicaid Services (CMS) published the Interoperability and Patient Access Final Rule.

HIPAA 62

HIPAA Compliance Health Services Administration Medicare 62

HIPAA Journal

JANUARY 9, 2023

Such major HIPAA updates placed a significant burden on HIPAA-covered entities and considerable time and effort were required to introduce new policies and procedures to ensure continued HIPAA compliance. What is certain is HIPAA officers and other compliance staff will have a busy few months when the Final Rule is published.

HIPAA 107

HIPAA COVID-19 COVID-19 Vaccine Compliance 107

C&M Health Law

JANUARY 25, 2023

Notably, the Act neither fulfilled the Biden Administration’s request for additional COVID-19 response funding nor included the Verifying Accurate Leading-edge In Vitro Clinical Test (IVCT) Development (VALID) Act, which proposed updating the current diagnostic testing regulatory framework.

Medicaid 104

Medicaid Medicaid Medicare Medicare 104